The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
The international COVID-19 pandemic has changed the behavior patterns of humanity. To date, more than 136 million people have suffered from the disease and more than 2.9 million of them have lost their lives. The symptoms ...
4 hours ago
0
0
